Showing results (201-210 of 328) with videos related to
Sort By:
Pageof 33
Journal of Cardiac Failure|November 5, 2019
Diastolic Dysfunction in Patients With Human Immunodeficiency Virus Receiving Antiretroviral Therapy: Results From the CHART StudyJaved Butler, Stephen J Greene, Svati H Shah, et al.JAMA Cardiology|November 13, 2020
Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights From the VICTORIA TrialCarolyn S P Lam, Anna Giczewska, Karen Sliwa, et al.Journal of Cardiac Failure|August 25, 2024
Comparing Analytical Methods for Composite End Points in Clinical Trials: Insights from the Vericiguat Global Study in Subjects with Heart Failure With Reduced Ejection Fraction TrialCynthia M Westerhout, Sarah Rathwell, Kevin J Anstrom, et al.Journal of Cardiac Failure|June 18, 2023
Classification of Heart Failure Events by Severity: Insights From the VICTORIA TrialG Michael Felker, Rebecca North, Hillary Mulder, et al.Journal of Cardiac Failure|July 3, 2021
Clinical Outcome Predictions for the VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) Trial: VICTORIA Outcomes ModelRobert J Mentz, Hillary Mulder, Arend Mosterd, et al.Circulation|November 12, 2015
Effects of Ranolazine on Angina and Quality of Life After Percutaneous Coronary Intervention With Incomplete Revascularization: Results From the Ranolazine for Incomplete Vessel Revascularization (RIVER-PCI) TrialKaren P Alexander, Giora Weisz, Kristi Prather, et al.Journal of Palliative Medicine|December 1, 2021
Race Differences in Quality of Life following a Palliative Care Intervention in Patients with Advanced Heart Failure: Insights from the Palliative Care in Heart Failure TrialRachel S Tobin, Marc D Samsky, Maragatha Kuchibhatla, et al.Journal of Cardiac Failure|November 13, 2012
Obesity and the response to intensified diuretic treatment in decompensated heart failure: a DOSE trial substudyAchal Gupta, Eugene Braunwald, Steven McNulty, et al.JACC. Heart Failure|October 17, 2017
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator: The VICTORIA TrialPaul W Armstrong, Lothar Roessig, Mahesh J Patel, et al.Journal of the American Heart Association|August 8, 2015
Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary PreventionPrateeti Khazanie, Anne S Hellkamp, Gregg C Fonarow, et al.Pageof 33